APEX1 and vulvar neoplasm: The effective sensitization of PDT-resistant cells with inhibitor of endonuclease activity of APE1, and likely low toxicity of such therapy for non-neoplastic cells, indicate a further research direction of combined treatment in vulvar neoplasms.